气滞胃痛颗粒联合莫沙必利治疗动力障碍型功能性消化不良60例  

Sixty Cases of Functional Dyspepsia of Dynamic Obstacle Type Treated with Qizhi Weitong Granules in Combination with Mosapride

作　　者：许彩儒 

机构地区：[1]北京市朝阳区南磨房社区卫生服务中心,北京100124

出　　处：《河南中医》2017年第6期1065-1066,共2页Henan Traditional Chinese Medicine

基　　金：北京市中医药科技项目(编号:JJ2005-03)

摘　　要：目的:观察气滞胃痛颗粒联合莫沙必利治疗动力障碍型功能性消化不良的临床疗效。方法:选取2014年6月—2015年6月在本院就诊的功能性消化不良患者60例,随机分为对照组和治疗组,每组30例。对照组给予莫沙必利口服治疗,治疗组在对照组治疗的基础上给予气滞胃痛颗粒治疗。结果:治疗组有效率为93.33%,对照组有效率为70.00%,治疗组优于对照组(P<0.05);治疗组治疗后临床症状积分、胃肠动力指数均优于对照组(P<0.05)。结论:气滞胃痛颗粒联合莫沙必利治疗动力障碍型功能性消化不良疗效显著。Objective ：To observe the clinical curative effect of Qizhi Weitong Granules （QZWTG） in combination with mosapride on functional dyspepsia of dynamic obstacle type. Methods ：Sixty patients with functional dyspepsia who were treated in our hospi- tal between June 2014 and June 2016 were chosen as the research subjects,and randomly divided into the control group and the treatment group,with 30 cases in each group. The ones in the control group were given mosapride for oral administration, while the ones in the treatment group were added QZWTG based on the treatment of the control group. Results ： The effective rate of the treatment group was 93.33% ,while that of the control group was 70% ,and the treatment group was better than the control group （ P 〈 0.05 ）. After the treatment, the clinical symptom scores and the gastrointestinal motility index in the treatment group were all better than those in the control group （ P 〈 0.05 ）. Conclusion ： QZWTG in combination with mosapride has a remarkable clinical curative effect on functional dyspepsia of dynamic obstacle type.

关 键 词：功能性消化不良 动力障碍型 气滞胃痛颗粒 

分 类 号：R259[医药卫生—中西医结合]